vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Yatsen Holding Ltd (YSG). Click either name above to swap in a different company.

Yatsen Holding Ltd is the larger business by last-quarter revenue ($164.2M vs $83.1M, roughly 2.0× PROCEPT BioRobotics Corp). Yatsen Holding Ltd runs the higher net margin — -0.5% vs -38.1%, a 37.6% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 24.5%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Yatsen Holding Ltd is a leading China-based beauty and personal care group. It develops and sells cosmetics, skincare products and fragrances under brands including Perfect Diary, Little Ondine and Abby's Choice, with core markets in mainland China, Southeast Asia, targeting Gen Z and young adult consumers.

PRCT vs YSG — Head-to-Head

Bigger by revenue
YSG
YSG
2.0× larger
YSG
$164.2M
$83.1M
PRCT
Higher net margin
YSG
YSG
37.6% more per $
YSG
-0.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
24.5%
YSG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
YSG
YSG
Revenue
$83.1M
$164.2M
Net Profit
$-31.6M
$-776.5K
Gross Margin
64.9%
77.8%
Operating Margin
-4.1%
-34.0%
Net Margin
-38.1%
-0.5%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
YSG
YSG
Q1 26
$83.1M
Q4 25
$76.4M
$164.2M
Q3 25
$83.3M
$95.1M
Q2 25
$79.2M
$110.9M
Q1 25
$69.2M
$106.6M
Q4 24
$68.2M
$147.0M
Q3 24
$58.4M
$102.3M
Q2 24
$53.4M
$118.1M
Net Profit
PRCT
PRCT
YSG
YSG
Q1 26
$-31.6M
Q4 25
$-29.8M
$-776.5K
Q3 25
$-21.4M
$-17.0M
Q2 25
$-19.6M
$-11.9M
Q1 25
$-24.7M
$-17.2M
Q4 24
$-18.9M
$-67.7M
Q3 24
$-21.0M
$-28.2M
Q2 24
$-25.6M
$-14.9M
Gross Margin
PRCT
PRCT
YSG
YSG
Q1 26
64.9%
Q4 25
60.6%
77.8%
Q3 25
64.8%
75.9%
Q2 25
65.4%
76.7%
Q1 25
63.9%
77.7%
Q4 24
64.0%
73.7%
Q3 24
63.2%
71.4%
Q2 24
59.0%
74.7%
Operating Margin
PRCT
PRCT
YSG
YSG
Q1 26
-4.1%
Q4 25
-40.6%
-34.0%
Q3 25
-27.8%
-20.9%
Q2 25
-28.0%
-17.0%
Q1 25
-39.7%
-20.4%
Q4 24
-28.9%
-50.3%
Q3 24
-38.4%
-32.2%
Q2 24
-50.3%
-15.7%
Net Margin
PRCT
PRCT
YSG
YSG
Q1 26
-38.1%
Q4 25
-39.1%
-0.5%
Q3 25
-25.7%
-17.9%
Q2 25
-24.7%
-10.8%
Q1 25
-35.8%
-16.1%
Q4 24
-27.6%
-46.1%
Q3 24
-35.9%
-27.6%
Q2 24
-48.0%
-12.6%
EPS (diluted)
PRCT
PRCT
YSG
YSG
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
YSG
YSG
Cash + ST InvestmentsLiquidity on hand
$245.6M
$109.4M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$428.9M
Total Assets
$487.1M
$550.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
YSG
YSG
Q1 26
$245.6M
Q4 25
$286.5M
$109.4M
Q3 25
$294.3M
$97.0M
Q2 25
$302.7M
$133.1M
Q1 25
$316.2M
$92.3M
Q4 24
$333.7M
$112.0M
Q3 24
$196.8M
$71.7M
Q2 24
$214.1M
$109.6M
Total Debt
PRCT
PRCT
YSG
YSG
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
YSG
YSG
Q1 26
$347.7M
Q4 25
$365.9M
$428.9M
Q3 25
$380.3M
$423.1M
Q2 25
$385.8M
$431.5M
Q1 25
$389.2M
$422.2M
Q4 24
$402.2M
$418.1M
Q3 24
$241.2M
$516.0M
Q2 24
$251.8M
$519.4M
Total Assets
PRCT
PRCT
YSG
YSG
Q1 26
$487.1M
Q4 25
$508.1M
$550.1M
Q3 25
$511.5M
$564.8M
Q2 25
$513.1M
$564.4M
Q1 25
$519.4M
$534.3M
Q4 24
$534.0M
$544.0M
Q3 24
$374.1M
$635.6M
Q2 24
$374.4M
$635.8M
Debt / Equity
PRCT
PRCT
YSG
YSG
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

YSG
YSG

Segment breakdown not available.

Related Comparisons